A pair of recent studies highlighted two potential new uses for metformin, a Type 2 diabetes drug. One points to the drug possibly helping people living with HIV, and another shows the drug could ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( NYSE:ABT) with a Overweight recommendation.

Living with diabetes comes with a lot of risks and managing it can be both difficult and expensive. Chief Medical Officer for Abbott Diabetes Care Dr. Mahmood Kazemi and Medicare Beneficiary Fran List ...

(HealthDay News) — After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

ScienceDaily: Some Diabetes Drugs Tied To Lower Risk Of Dementia, Parkinson's Disease A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, ...

The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn't produce enough insulin or i ...

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...